Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Nov;113(3):987–993. doi: 10.1111/j.1476-5381.1994.tb17090.x

The transhepatic action of ATP on the hepatic arterial and portal venous vascular beds of the rabbit: the role of nitric oxide.

D J Browse 1, R T Mathie 1, I S Benjamin 1, B Alexander 1
PMCID: PMC1510453  PMID: 7858895

Abstract

1. The effect of bolus administration of adenosine 5'-triphosphate (ATP) into the portal vein on hepatic arterial pressure (the transhepatic action of ATP) and portal venous pressure, and the contribution of nitric oxide towards these responses, was studied in the in vitro dual-perfused rabbit liver. 2. At basal tone, hepatic arterial and portal venous vasoconstriction followed ATP injection, while at a tone raised with methoxamine (10(-6)-10(-5) M) ATP caused hepatic arterial vasodilatation, and a phasic vasodilatation followed by vasoconstriction in the portal venous vascular bed. 3. To determine whether the transhepatic arterial dilatation was due to the diffusion of nitric oxide (NO) from the portal venous vasculature, NG-nitro-L-arginine methyl ester (L-NAME, 100 microM), an inhibitor of NO synthesis, was infused selectively into the portal vein. L-NAME infusion potentiated portal venous vasoconstriction to ATP (-log M ED50 5.32 +/- 0.31 to 6.51 +/- 0.43, P < 0.05, Student's paired t test) indicating the possible inhibition of a NO-mediated vasodilator component of the portal venous response to ATP. There was, however, no demonstrable difference in the transhepatic arterial vasodilatation induced by ATP during this infusion. 4. Simultaneous perfusion of both the hepatic arterial and portal venous inflows with L-NAME (100 microM) resulted in a significant decrease in the amplitude of hepatic arterial responses to ATP demonstrating that these responses were ultimately mediated by an NO-dependent mechanism. 5. This study has thus demonstrated a vasodilator component of the portal venous response to ATP that is NO-mediated.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
987

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander B., Mathie R. T., Ralevic V., Burnstock G. An isolated dual-perfused rabbit liver preparation for the study of hepatic blood flow regulation. J Pharmacol Toxicol Methods. 1992 Mar;27(1):17–22. doi: 10.1016/1056-8719(92)90015-s. [DOI] [PubMed] [Google Scholar]
  2. Belloni F. L., Elkin P. L., Giannotto B. The mechanism of adenosine release from hypoxic rat liver cells. Br J Pharmacol. 1985 Jun;85(2):441–446. doi: 10.1111/j.1476-5381.1985.tb08880.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bergfeld G. R., Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res. 1992 Jan;26(1):40–47. doi: 10.1093/cvr/26.1.40. [DOI] [PubMed] [Google Scholar]
  4. Bodin P., Bailey D., Burnstock G. Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br J Pharmacol. 1991 May;103(1):1203–1205. doi: 10.1111/j.1476-5381.1991.tb12324.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boeynaems J. M., Galand N. Stimulation of vascular prostacyclin synthesis by extracellular ADP and ATP. Biochem Biophys Res Commun. 1983 Apr 15;112(1):290–296. doi: 10.1016/0006-291x(83)91829-6. [DOI] [PubMed] [Google Scholar]
  6. Brizzolara A. L., Burnstock G. Endothelium-dependent and endothelium-independent vasodilatation of the hepatic artery of the rabbit. Br J Pharmacol. 1991 May;103(1):1206–1212. doi: 10.1111/j.1476-5381.1991.tb12325.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brizzolara A. L., Burnstock G. Evidence for noradrenergic-purinergic cotransmission in the hepatic artery of the rabbit. Br J Pharmacol. 1990 Apr;99(4):835–839. doi: 10.1111/j.1476-5381.1990.tb13016.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brizzolara A. L., Crowe R., Burnstock G. Evidence for the involvement of both ATP and nitric oxide in non-adrenergic, non-cholinergic inhibitory neurotransmission in the rabbit portal vein. Br J Pharmacol. 1993 Jul;109(3):606–608. doi: 10.1111/j.1476-5381.1993.tb13614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Buxton I. L., Cheek D. J., Eckman D., Westfall D. P., Sanders K. M., Keef K. D. NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 1993 Feb;72(2):387–395. doi: 10.1161/01.res.72.2.387. [DOI] [PubMed] [Google Scholar]
  10. Falcone J. C., Bohlen H. G. EDRF from rat intestine and skeletal muscle venules causes dilation of arterioles. Am J Physiol. 1990 May;258(5 Pt 2):H1515–H1523. doi: 10.1152/ajpheart.1990.258.5.H1515. [DOI] [PubMed] [Google Scholar]
  11. Gordon J. L. Extracellular ATP: effects, sources and fate. Biochem J. 1986 Jan 15;233(2):309–319. doi: 10.1042/bj2330309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kennedy C., Burnstock G. Evidence for two types of P2-purinoceptor in longitudinal muscle of the rabbit portal vein. Eur J Pharmacol. 1985 Apr 23;111(1):49–56. doi: 10.1016/0014-2999(85)90112-8. [DOI] [PubMed] [Google Scholar]
  13. Lautt W. W., Legare D. J., Daniels T. R. The comparative effect of administration of substances via the hepatic artery or portal vein on hepatic arterial resistance, liver blood volume and hepatic extraction in cats. Hepatology. 1984 Sep-Oct;4(5):927–932. doi: 10.1002/hep.1840040524. [DOI] [PubMed] [Google Scholar]
  14. Lautt W. W., Legare D. J., d'Almeida M. S. Adenosine as putative regulator of hepatic arterial flow (the buffer response). Am J Physiol. 1985 Mar;248(3 Pt 2):H331–H338. doi: 10.1152/ajpheart.1985.248.3.H331. [DOI] [PubMed] [Google Scholar]
  15. Lautt W. W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol. 1985 Nov;249(5 Pt 1):G549–G556. doi: 10.1152/ajpgi.1985.249.5.G549. [DOI] [PubMed] [Google Scholar]
  16. Le Grand B., Marty A., Vié B., Patoiseau J. F., John G. W. Prevention by specific chemical classes of alpha 1-adrenoceptor antagonists of veratrine-contractures in rat left atria independently of alpha 1-adrenoceptor blockade. Br J Pharmacol. 1994 May;112(1):195–199. doi: 10.1111/j.1476-5381.1994.tb13051.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lee J. W., Filkins J. P. Exogenous ATP and hepatic hemodynamics in the perfused rat liver. Circ Shock. 1988 Feb;24(2):99–110. [PubMed] [Google Scholar]
  18. Mathie R. T., Alexander B. The role of adenosine in the hyperaemic response of the hepatic artery to portal vein occlusion (the 'buffer response'). Br J Pharmacol. 1990 Jul;100(3):626–630. doi: 10.1111/j.1476-5381.1990.tb15857.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mathie R. T., Lam P. H., Harper A. M., Blumgart L. H. The hepatic arterial blood flow response to portal vein occlusion in the dog: the effect of hepatic denervation. Pflugers Arch. 1980 Jul;386(1):77–83. doi: 10.1007/BF00584191. [DOI] [PubMed] [Google Scholar]
  20. Mathie R. T., Ralevic V., Alexander B., Burnstock G. Nitric oxide is the mediator of ATP-induced dilatation of the rabbit hepatic arterial vascular bed. Br J Pharmacol. 1991 Jun;103(2):1602–1606. doi: 10.1111/j.1476-5381.1991.tb09834.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Moore P. K., al-Swayeh O. A., Chong N. W., Evans R. A., Gibson A. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol. 1990 Feb;99(2):408–412. doi: 10.1111/j.1476-5381.1990.tb14717.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Paddle B. M., Burnstock G. Release of ATP from perfused heart during coronary vasodilatation. Blood Vessels. 1974;11(3):110–119. doi: 10.1159/000158005. [DOI] [PubMed] [Google Scholar]
  23. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  24. Pearson J. D., Carleton J. S., Gordon J. L. Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J. 1980 Aug 15;190(2):421–429. doi: 10.1042/bj1900421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pearson J. D., Carleton J. S., Hutchings A., Gordon J. L. Uptake and metabolism of adenosine by pig aortic endothelial and smooth-muscle cells in culture. Biochem J. 1978 Feb 15;170(2):265–271. doi: 10.1042/bj1700265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ralevic V., Mathie R. T., Alexander B., Burnstock G. Characterization of P2X- and P2Y-purinoceptors in the rabbit hepatic arterial vasculature. Br J Pharmacol. 1991 May;103(1):1108–1113. doi: 10.1111/j.1476-5381.1991.tb12308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ralevic V., Milner P., Kirkpatrick K. A., Burnstock G. Flow-induced release of adenosine 5'-triphosphate from endothelial cells of the rat mesenteric arterial bed. Experientia. 1992 Jan 15;48(1):31–34. doi: 10.1007/BF01923600. [DOI] [PubMed] [Google Scholar]
  28. Reilly W. M., Burnstock G. The effect of ATP analogues on the spontaneous electrical and mechanical activity of rat portal vein longitudinal muscle. Eur J Pharmacol. 1987 Jun 26;138(3):319–325. doi: 10.1016/0014-2999(87)90469-9. [DOI] [PubMed] [Google Scholar]
  29. Reilly W. M., Saville V. L., Burnstock G. An assessment of the antagonistic activity of reactive blue 2 at P1- and P2-purinoceptors: supporting evidence for purinergic innervation of the rabbit portal vein. Eur J Pharmacol. 1987 Aug 4;140(1):47–53. doi: 10.1016/0014-2999(87)90632-7. [DOI] [PubMed] [Google Scholar]
  30. Su C. Extracellular functions of nucleotides in heart and blood vessels. Annu Rev Physiol. 1985;47:665–676. doi: 10.1146/annurev.ph.47.030185.003313. [DOI] [PubMed] [Google Scholar]
  31. Withrington P. G. The actions of two sensory neuropeptides, substance P and calcitonin gene-related peptide, on the canine hepatic arterial and portal vascular beds. Br J Pharmacol. 1992 Oct;107(2):296–302. doi: 10.1111/j.1476-5381.1992.tb12741.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES